Table 1 Data comparison between patients with MVO and without MVO
Variables | With MVO (N=57) | Without MVO (N=35) | ||
|---|---|---|---|---|
| Â | Baseline | Follow-up | Baseline | Follow-up |
Infarct size, %LV | 38.3±10.5§ | 29.5±10.5*# | 30.3±11.0 | 22.7±9.8* |
LVEF, % | 40.4±7.6§ | 46.7±7.6*# | 44.3±6.5 | 51.9±7.3* |
LVEDV, mL | 185.2±32.9 | 199.0±34.4*# | 170.2±32.4 | 170.1±30.2 |
LVESV, mL | 111.1±27.3§ | 107.3±30.1# | 94.5±19.6 | 81.8±19.3* |
∆LVEF, % | 6.3±6.3 | 7.6±5.9 | ||
∆LVEDV, mL | 13.8±23.7 | -0.13±16.6†| ||
∆LVEDV, % | 8.3±12.8 | 0.76±10.6†| ||
∆LVESV, mL | -3.8±20.8 | -12.7±11.8†| ||
∆LVESV, % | -2.7±16.6 | -13.0±12.9†| ||